Characterisation of extended spectrum β-lactamase among Escherichia coli and Klebsiella pneumoniae associated with skin and urogenital tract infections in dog

SUSMI T PAULSON; SURYA SANKAR; BINU K MANI; V R AMBILY; THANKSY S AKKARA; ANU BOSEWELL; M MINI

doi:10.56093/ijans.v89i7.92016

Authors

SUSMI T PAULSON MSc Scholar, College of Veterinary and Animal Sciences, Mannuthy, Kerala 680 651 India
SURYA SANKAR Assistant Professor, College of Veterinary and Animal Sciences, Mannuthy, Kerala 680 651 India
BINU K MANI Assistant Professor, Department of Veterinary Microbiology, College of Veterinary and Animal Sciences, Waynad, Kerala
V R AMBILY Assistant Professor, Department of Veterinary Clinical Medicine Ethics and Jurisprudence, College of Veterinary and Animal Sciences, Mannuthy, Kerala.
THANKSY S AKKARA MSc Scholar, College of Veterinary and Animal Sciences, Mannuthy, Kerala 680 651 India
ANU BOSEWELL Junior Research Fellow, College of Veterinary and Animal Sciences, Mannuthy, Kerala 680 651 India
M MINI Professor and Head, College of Veterinary and Animal Sciences, Mannuthy, Kerala 680 651 India

https://doi.org/10.56093/ijans.v89i7.92016

Keywords:

blaTEM, blaCTX-M, blaSHV, Escherichia coli, Extended spectrum beta-lactamase, Klebsiella pneumoniae

Abstract

Thus, ESBL producing organisms pose a major problem for clinical therapeutics. Because of the close contact between dogs and man, and aimless utilization of antibiotics especially cephalosporins in veterinary sector, these animals have turned into potential source of ESBL producing bacteria, thereby prompting the transfer of multidrug resistant strains in human. So far no studies have been conducted regarding the prevalence of ESBL among animals in Kerala. Because of the alarming rise in the number of these resistant strains, there is a urgent need for regular area based monitoring of the antibiogram profile of the various bacterial organisms associated with clinical infections in animals which could fluctuate throughout the years and from site to site. This could provide adequate data prompting the authorities to formulate strict antibiotic usage guidelines in veterinary and human sector.

Downloads

Download data is not yet available.

References

Agrawal P, Ghosh A N, Kumar S, Basu B and Kapila K. 2008. Prevalence of ESBL among E. coli and Klebsiella pneumoniae isolates in a tertiary care hospital. Indian Journal of Pathology and Microbiology 51(1): 139–42. DOI: https://doi.org/10.4103/0377-4929.40428

Ahmed S M, Rajeevan S, Jasmin P T and Shakir V P. 2014. Detection of ESBL among the Gram negative uropathogens and their antibiotic resistance pattern in a rural medical college hospital North Kerala, India. International Journal of Current Microbiology and Applied Sciences 3: 561–67.

Bassessar V, Verma Y and Swami M. 2013. Antibiogram of bacterial species isolated from canine pyometra. Veterinary World 6: 546–49. DOI: https://doi.org/10.5455/vetworld.2013.546-549

Bell J M, Chitsaz M, Turnidge J D, Barton M, Walters L J and Jones R N. 2007. Prevalence and significance of a negative ESBL confirmation test result after a positive ESBL screening test result for isolates of E. coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance program. Journal of Clinical Microbiology 45(5): 1478–82. DOI: https://doi.org/10.1128/JCM.02470-06

Bora A, Hazarika K N, Shukla K S, Prasad N K, Sarma B J and Ahmed G. 2017. Prevalence of blaTEM, blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India. Indian Journal of Pathology Microbiology 57: 249–59. DOI: https://doi.org/10.4103/0377-4929.134698

Chaudhary U and Aggrawal R. 2004. Extended spectrum lactamases (ESBL)—An emerging threat to clinical therapeutics. Indian Journal of Medical Microbiology 22(2): 75–80. DOI: https://doi.org/10.1016/S0255-0857(21)02884-X

Clinical and Laboratory Standard Institute. 2011. Performance Standards for Antimicrobial Susceptibility Testing. 21st International Supplement M100-S21. CLSI, Wayne, PA, USA. Goosens H. 2001. Summary of European data from 1997 to 2000. Diagnostic Microbiology Infectious Diseases 41: 183–89.

Nisha V K, Shenoy D R, Shetty V A, Shinoy M V and Shetty K A. 2015. Trends in antimicrobial resistance among uropathogens with special reference to Escherichia coli in community acquired pediatric urinary tract infections from Kerala. Journal of Evolution of Medical and Dental Sciences 4: 9313–20. DOI: https://doi.org/10.14260/jemds/2015/1354

Paterson L D and Bonomo A R. 2005. Extended-spectrum beta- lactamases: a clinical update. Clinical Microbiology Reviews 18: 657–86. DOI: https://doi.org/10.1128/CMR.18.4.657-686.2005

Shakya P, Shrestha D, Maharjan E, Sharma V K and Paudyal R. 2017. ESBL production among E. coli and Klebsiella spp. causing urinary tract infection: A hospital base study. Open Microbiology Journal 11: 23–30. DOI: https://doi.org/10.2174/1874285801711010023

Shetty J. 2017. Skin and soft tissue infections associated with methicillin resistant Staphylococcus aureus, ESBL, Amp C and metallo -Lactamase producing bacilli in a tertiary care hospital. Journal of Dental and Medical Sciences 16: 08–14. DOI: https://doi.org/10.9790/0853-1606070814

Zogg L A, Simmen S, Zurfluh K, Stephan R, Schmitt N S and Neusch-inderbinen M. 2018. High prevalence of extended- spectrum -lactamase producing Enterobacteriaceae among clinical isolates from cats and dogs admitted to a veterinary hospital in Switzerland. Frontiers in Veterinary Science 5: 62–68. DOI: https://doi.org/10.3389/fvets.2018.00062